(Q46531270)

22 December 2017

title

A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer (English)

1 reference

22 December 2017

1 reference

1 reference

1 reference

1 reference

D W Rea

1

1 reference

22 December 2017

J W R Nortier

2

1 reference

22 December 2017

W W Ten Bokkel Huinink

3

1 reference

22 December 2017

S Falk

4

1 reference

22 December 2017

D J Richel

5

1 reference

22 December 2017

T Maughan

6

1 reference

22 December 2017

G Groenewegen

7

1 reference

22 December 2017

J M Smit

8

1 reference

22 December 2017

N Steven

9

1 reference

22 December 2017

J M Bakker

10

1 reference

22 December 2017

D Semiond

11

1 reference

22 December 2017

D J Kerr

12

1 reference

22 December 2017

C J A Punt

13

1 reference

22 December 2017

language of work or name

1 reference

6 June 2005

1 reference

22 December 2017

published in

Annals of Oncology

1 reference

22 December 2017

volume

16

1 reference

22 December 2017

issue

7

1 reference

22 December 2017

page(s)

1123-1132

1 reference

22 December 2017

New options and old dilemmas in the treatment of patients with advanced colorectal cancer

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI227

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDI227

1 reference

22 December 2017

1 reference

22 December 2017